These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9608408)

  • 21. Clozapine as a treatment for psychosis in Parkinson's disease: a review.
    Musser WS; Akil M
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):1-9. PubMed ID: 8845691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
    Factor SA; Molho ES; Brown DL
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine for psychosis in Parkinson's disease.
    Pfeiffer RF; Kang J; Graber B; Hofman R; Wilson J
    Mov Disord; 1990; 5(3):239-42. PubMed ID: 2388641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine deficiency may lead to capgras syndrome in Parkinson's disease with dementia.
    Shiotsuki H; Motoi Y; Nakamura S; Mizuno Y; Hattori N
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352i.e14-352.e15. PubMed ID: 20686153
    [No Abstract]   [Full Text] [Related]  

  • 25. Olanzapine-induced gynecomastia.
    Mendhekar DN; Srilakshmi P
    Aust N Z J Psychiatry; 2005 Aug; 39(8):736. PubMed ID: 16050930
    [No Abstract]   [Full Text] [Related]  

  • 26. Donepezil in the treatment of hallucinations and delusions in Parkinson's disease.
    Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Lenzi GL; Meco G
    Neurol Sci; 2002 Apr; 23(1):41-3. PubMed ID: 12111620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Othello syndrome in patients with Parkinson's disease.
    Georgiev D; Danieli A; Ocepek L; Novak D; Zupancic-Kriznar N; Trost M; Pirtosek Z
    Psychiatr Danub; 2010 Mar; 22(1):94-8. PubMed ID: 20305599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours.
    Friedman JH; Agarwal P; Alcalay R; Black KJ; Chou KL; Cote L; Dayalu P; Frank S; Hartlein J; Hauser RA; Lang AE; Marsh L; Marshall F; Moskowitz C; Ravina B; Riley D; Sanchez-Ramos J; Simon DK; Simuni T; Sutton J; Tuite P; Weintraub D; Zesiewicz T
    Int J Neurosci; 2011 Aug; 121(8):472-6. PubMed ID: 21663381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine.
    Rudolf J; Ghaemi M; Schmülling S
    Eur Psychiatry; 1999 Oct; 14(6):356-7. PubMed ID: 10572371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing psychosis in patients with Parkinson's disease.
    Cummings JL
    N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolated delusional syndrome in Parkinson's Disease.
    Stefanis N; Bozi M; Christodoulou C; Douzenis A; Gasparinatos G; Stamboulis E; Stefanis C; Stefanis L
    Parkinsonism Relat Disord; 2010 Sep; 16(8):550-2. PubMed ID: 20620094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of clozapine and levodopa for the treatment of persistent visual hallucinations and parkinsonism in Lewy body dementia].
    Archie A; Persoons P; Vandenbulcke M
    Tijdschr Psychiatr; 2013; 55(4):287-91. PubMed ID: 23595844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hallucinations and delusions associated with Parkinson's disease psychosis: safety of current treatments and future directions.
    Isaacson SH; Citrome L
    Expert Opin Drug Saf; 2022 Jul; 21(7):873-879. PubMed ID: 35466847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine for the treatment of psychosis in Parkinson's disease: a review.
    Auzou P; Ozsancak C; Hannequin D; Moore N; Augustin P
    Acta Neurol Scand; 1996 Nov; 94(5):329-36. PubMed ID: 8947285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.
    Molho ES; Factor SA
    Curr Neurol Neurosci Rep; 2001 Jul; 1(4):320-8. PubMed ID: 11898537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.
    Scholz E; Dichgans J
    Eur Arch Psychiatry Neurol Sci; 1985; 235(1):60-4. PubMed ID: 2864254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delusional Parasitosis as a Treatment Complication of Parkinson Disease.
    Ojeda-López C; Aguilar-Venegas LC; Tapia-Orozco M; Cervantes-Arriaga A; Rodríguez-Violante M
    Psychosomatics; 2015; 56(6):696-9. PubMed ID: 26481963
    [No Abstract]   [Full Text] [Related]  

  • 38. [Emotional and cognitive disorders in Parkinson disease].
    Arsland D; Larsen JP
    Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.
    Panchal SC; Ondo WG
    Curr Psychiatry Rep; 2018 Jan; 20(1):3. PubMed ID: 29374325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delusional misidentification syndrome: why such nosologic challenge remains intractable.
    Rodrigues AC; Banzato CE
    Psychopathology; 2006; 39(6):296-302. PubMed ID: 16974136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.